Genitourinary Cancer

Immunotherapy + Chemo May Improve Outcomes in Metastatic Urothelial Cancer

By

Jody A. Charnow, Editor

Publish Date October 3, 2019

First-line treatment with both atezolizumab and platinum-based chemotherapy (PBC) is associated with prolonged progression-free survival vs PBC alone in patients with metastatic urothelial cancer, a study found.

Women Have Lower Relative Survival After Bladder Cancer Diagnosis

By

Natasha Persaud

Publish Date September 25, 2019

In a study, women with bladder cancer had approximately 1.5-fold higher mortality than men — but only in the short term.

Best Practices for Handling BCG Waste

By

Jiajoyce R. Conway, DNP, CRNP, AOCNP

Publish Date August 27, 2019

What is the proper procedure for handling bacillus Calmette-Guerin (BCG) waste? Does the room need to be closed off after instilling the drug into the bladder?

Quitting Smoking Lowers Risk for Bladder Cancer Postmenopause

Publish Date May 29, 2019

Significant drop seen in first 10 years of cessation, continues to decrease as cessation time increases.

Durvalumab for the Management of Urothelial Carcinoma: A Short Review on the Emerging Data and Therapeutic Potential

Publish Date May 24, 2019

A review of durvalumab, an immune checkpoint inhibitor approved for the treatment of urothelial carcinoma.